ARCHIVES

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

November 12, 2004

NCI CTEP-Approved Trials For the Month of August

August 29, 2014

Agency Asks GnRH Sponsors To Add Warnings On Labels

October 22, 2010

In Brief: No Intention Of Retiring, DeVita Says; Bresnick To Head Eppley; Balch Acting Director at Alabama

October 22, 1982

Reagan Family History Shows String Risk Factor

August 2, 1985